Helicobacter Pylori Resistance. A Study of Morbidity, Immunological and Clinical Phenotypes
Helicobacter Pylori Resistance. A Study of Morbidity, Immunological and Clinical Phenotypes
The main goal of the study was to characterize the morbidity, immunological, microbiolical and clinical phenotypes of patients with treated- resistance to Helicobacter pylori (HP) infection, and the effect of triple therapy including the levofloxacin. Control groups were newly diagnosed, previously infected and never infected HP patients
See Nestegard O, et al. PLOS ONE | https://doi.org/10.1371/journal.pone.0238944 September 23, 2020
Inclusion Criteria:
Patients referred to a GI- unite with upper GI complains and performing an upper endoscopy -
Exclusion Criteria:
Patients with severe chronic diseases and not willing to participate